Sponsor
First People's Hospital of Foshan
Clinical research sponsor
Clinical trials
14 shownDifferentiation of Benign and Malignant Pulmonary Nodules by Volatile Organic Compounds in Human Exhaled BreathNCT06518655 · collaborator · 2024-06-30
RECRUITINGIdentification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled BreathNCT06528418 · collaborator · 2024-06-30
RECRUITINGBreast Phyllodes Tumors: Based on 20-year Real-world Data From ChinaNCT07636096 · collaborator · 2026-05-01
COMPLETEDLiposomal Irinotecan Combination Regimen for First-line Treatment of Small Cell Lung CancerNCT06462105 · collaborator · 2024-07-05
NOT_YET_RECRUITINGLobectomy-First vs. Lymphadenectomy-First for Operable NSCLC (LOFTY)NCT06577792 · collaborator · 2023-08-16
ACTIVE_NOT_RECRUITINGEnsartinib in Combination With Bevacizumab in ALK-positive NSCLC Patients With TP53 MutationNCT05491811 · collaborator · 2022-08-01
ACTIVE_NOT_RECRUITINGThe Characteristics, Treatment Patterns and Prognosis of Chinese Male Breast Cancer: A Real-world StudyNCT06220630 · collaborator · 2021-08-01
UNKNOWNOsimertinib Monotherapy or Combination With Chemotherapy for Advanced NSCLC Concurrent EGFR and TP53 MutationsNCT04695925 · collaborator · 2021-03-29
ACTIVE_NOT_RECRUITINGChemoradiotherapy With or Without Sintilimab in Limited-stage SCLCNCT04189094 · collaborator · 2020-01-01
UNKNOWNLocoregional Surgery of the Primary Tumor in de Novo Stage IV Breast Cancer PatientsNCT04456855 · collaborator · 2019-09-01
UNKNOWNMRI-based Approaches for Multi-parametric Model to Early Predict Pathological Complete Response to Neoadjuvant Therapy in Breast CancerNCT04909554 · collaborator · 2019-01-01
COMPLETEDAssociation of Survival With Maintenance Therapy in Patients With Metastatic Breast Cancer After First-line ChemotherapyNCT04258163 · collaborator · 2019-01-01
COMPLETEDEffects of Different Early Intensive Therapies on Long-term β-cell FunctionNCT01471808 · collaborator · 2011-10-01
COMPLETEDUltrasonographic Monitoring of Response to Infliximab in Patients With Rheumatoid ArthritisNCT01282528 · collaborator · 2010-09-01
UNKNOWNSponsor roles
collaborator14
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.